Both abdominal obesity and sarcopenia are associated with cardiometabolic disorders mainly in postmenopausal women. In addition, there appears to be a reverse association between abdominal obesity and sarcopenia. The objective of the study was to identify the association and the discriminatory power of abdominal obesity for the prevention of sarcopenia and vice versa in postmenopausal women. The sample includes 257 women with age 57,2 years, The abdominal obesity and the variables determinants of sarcopenia were assessed by bioelectrical impedance analysis. The association of variables was been tested using logistic regression and the discriminatory power through Receiver Operating Characteristic (ROC) considering a confidence interval of 95%. The presence of abdominal obesity with the cutoff point of 153 cm² of visceral fat was discriminatory power for sarcopenia, as well as the musculoskeletal mass index with the cuttof point of 35,2% discriminated the absence of abdominal obesity. After adjusting for confounders it was observed still association between abdominal obesity and sarcopenia and association between musculoskeletal mass index and absence of abdominal obesity. The results of the study suggest that abdominal obesity discriminates and is associated with sarcopenia, such as musculoskeletal mass index discriminates the absence and is inversely associated whit of abdominal obesity in postmenopausal women.
Published in | European Journal of Preventive Medicine (Volume 6, Issue 5) |
DOI | 10.11648/j.ejpm.20180605.12 |
Page(s) | 70-75 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2018. Published by Science Publishing Group |
Abdominal Obesity, Sarcopenia, Postmenopausal Women
[1] | Roubenoff R, Sarcopenic obesity: the confluence of two epidemics, Obes Res, 2004 Jun; 12(6): 887-8. |
[2] | Björntorp P, Adipose tissue distribuition and function, Int J Obes 1991; 15 Suppl 2: 67-81. |
[3] | Sakuma K, Yamaguchi A (2010) Molecular mechanisms in aging and current strategies to counteract sarcopenia, Curr Aging Sci 3: 90–101. |
[4] | Kim TN, Park MS, Ryu JY, Choi HY, Hong HC, et al, (2014) Impact of Visceral Fat on Skeletal Muscle Mass and Vice Versa in a Prospective Cohort Study: The Korean Sarcopenic Obesity Study (KSOS), PLoS ONE 9(12): e115407, doi: 10,1371/journal,pone,0115407. |
[5] | Hong HC, Hwang SY, Choi HY, et al, Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study, Hepatology 2014; 59: 1772-1778. |
[6] | Han K, Park YM, Kwon HS, et al, Sarcopenia as a determinant of blood pressure in older Koreans: findings from the Korea National Health and Nutrition Examination Surveys (KNHANES) 2008-2010, PLoS One 2014; 9: e86902. |
[7] | Kimmerle R, Heinemann L, Heise T, Bender R, Weyer C, Hirschberger S, Berger M. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women. Menopause. 1999; 6(1): 36-42. |
[8] | Moreira, H, Influência do Exercício Físico no Risco Cardiovascular e na Aptidão Física e Funcional de Mulheres Pós-Menopáusicas, F, p, a, C, e, Tecnologia, Editor 2004: Vila Real. |
[9] | World Medical Association, World medical association declaration of Helsinki: ethical principles for medical research involving human subjects, ed, Seoul: WMA General Assembly, 2008. |
[10] | Heyward, V, H, and D, Wagner, R, Applied Body Composition Assessment, Second Edition ed, 2004, Champaign: Human Kinetics. |
[11] | Biospace, ed, InBody 720 the precision body composition analyser: user´s manual, ed, L, Biospace Co, 2008, Biospace Co, Ltd,: Seoul. |
[12] | Chumlea, W, & Sun, S, (2005), Bioelectrical impedance analysis, In S, Heymsfield, T, Lohman, Z, Wang & S, Going (Eds,), Human body composition (pp, 79-88), Champaign: Human Kinetics. |
[13] | Janssen, I, Heymsfield, S, & Ross, R, (2002), Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability, Journal of the American Geriatrics Society, 50(5), 889-896, doi: 10,1046/j,1532-5415,2002,50216,x. |
[14] | Ling, C, Craen, A, Slagboom, P, Gunn, D, Stokkel, M, Westendorp, R, Maier, A, (2011), Accuracy of direct segmental multi-frequency bioimpedance analysis in the assessment of total body and segmental body composition in middle-aged adult population, Clinical Nutrition, 30(5), 610-615, doi: 10,1016/j,clnu,2011,04,00. |
[15] | Hosmer, D, & Lemeshow, S, (2005), Applied logistic regression (2ª ed,), New York: John Wiley & Sons, Inc. |
[16] | Choi KM, Sarcopenia and sarcopenic obesity, Korean J Intern Med, 2016 Nov; 31(6): 1054-1060. |
[17] | Lim KI, Yang SJ, Kim TN, Yoo HJ, Kang HJ, et al, (2010) The association between the ratio of visceral fat to thigh muscle area and metabolic syndrome: the Korean Sarcopenic Obesity Study (KSOS), Clin Endocrinol (Oxf) 73: 588–594. |
[18] | Masgrau A, Mishellany-Dutour A, Murakami H, Beaufrere AM, Walrand S, et al, (2012) Time-course changes of muscle protein synthesis associated with obesity-induced lipotoxicity, J Physiol 590: 5199–5210. |
[19] | Pitanga CP, Pitanga FJ, Beck CC, Gabriel RE, Moreira MH, [Level of physical activity in the prevention of excess visceral fat in postmenopausal women: how much is needed?], Arq Bras Endocrinol Metabol, 2012; 56(6): 358-63. |
[20] | Pitanga FJ, Pitanga CP, Beck CC, Gabriel RE, Moreira MH, Anthropometry to identify high visceral fat area in postmenopausal women, Nutr Hosp, 2015; 32(6): 2535-9. |
[21] | Pitanga, C. P. S., Pitanga, F. J. G., Moreira, M. H. R., Gabriel, R. E. C. Associação entre o nível de atividade física e a área de gordura visceral emmulheres pós-menopáusicas. Rev. Bras. Med. Esporte. 2014; 20(4): 252–256. |
APA Style
Francisco José Gondim Pitanga, Cristiano Penas Seara Pitanga, Ronaldo Eugénio Calçada Dias Gabriel, Carmem Cristina Beck, Maria Helena Rodrigues Moreira. (2018). Association and Discriminatory Power of Abdominal Obesity for the Prevention of Sarcopenia and Vice Versa in Postmenopausal Women. European Journal of Preventive Medicine, 6(5), 70-75. https://doi.org/10.11648/j.ejpm.20180605.12
ACS Style
Francisco José Gondim Pitanga; Cristiano Penas Seara Pitanga; Ronaldo Eugénio Calçada Dias Gabriel; Carmem Cristina Beck; Maria Helena Rodrigues Moreira. Association and Discriminatory Power of Abdominal Obesity for the Prevention of Sarcopenia and Vice Versa in Postmenopausal Women. Eur. J. Prev. Med. 2018, 6(5), 70-75. doi: 10.11648/j.ejpm.20180605.12
AMA Style
Francisco José Gondim Pitanga, Cristiano Penas Seara Pitanga, Ronaldo Eugénio Calçada Dias Gabriel, Carmem Cristina Beck, Maria Helena Rodrigues Moreira. Association and Discriminatory Power of Abdominal Obesity for the Prevention of Sarcopenia and Vice Versa in Postmenopausal Women. Eur J Prev Med. 2018;6(5):70-75. doi: 10.11648/j.ejpm.20180605.12
@article{10.11648/j.ejpm.20180605.12, author = {Francisco José Gondim Pitanga and Cristiano Penas Seara Pitanga and Ronaldo Eugénio Calçada Dias Gabriel and Carmem Cristina Beck and Maria Helena Rodrigues Moreira}, title = {Association and Discriminatory Power of Abdominal Obesity for the Prevention of Sarcopenia and Vice Versa in Postmenopausal Women}, journal = {European Journal of Preventive Medicine}, volume = {6}, number = {5}, pages = {70-75}, doi = {10.11648/j.ejpm.20180605.12}, url = {https://doi.org/10.11648/j.ejpm.20180605.12}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ejpm.20180605.12}, abstract = {Both abdominal obesity and sarcopenia are associated with cardiometabolic disorders mainly in postmenopausal women. In addition, there appears to be a reverse association between abdominal obesity and sarcopenia. The objective of the study was to identify the association and the discriminatory power of abdominal obesity for the prevention of sarcopenia and vice versa in postmenopausal women. The sample includes 257 women with age 57,2 years, The abdominal obesity and the variables determinants of sarcopenia were assessed by bioelectrical impedance analysis. The association of variables was been tested using logistic regression and the discriminatory power through Receiver Operating Characteristic (ROC) considering a confidence interval of 95%. The presence of abdominal obesity with the cutoff point of 153 cm² of visceral fat was discriminatory power for sarcopenia, as well as the musculoskeletal mass index with the cuttof point of 35,2% discriminated the absence of abdominal obesity. After adjusting for confounders it was observed still association between abdominal obesity and sarcopenia and association between musculoskeletal mass index and absence of abdominal obesity. The results of the study suggest that abdominal obesity discriminates and is associated with sarcopenia, such as musculoskeletal mass index discriminates the absence and is inversely associated whit of abdominal obesity in postmenopausal women.}, year = {2018} }
TY - JOUR T1 - Association and Discriminatory Power of Abdominal Obesity for the Prevention of Sarcopenia and Vice Versa in Postmenopausal Women AU - Francisco José Gondim Pitanga AU - Cristiano Penas Seara Pitanga AU - Ronaldo Eugénio Calçada Dias Gabriel AU - Carmem Cristina Beck AU - Maria Helena Rodrigues Moreira Y1 - 2018/11/10 PY - 2018 N1 - https://doi.org/10.11648/j.ejpm.20180605.12 DO - 10.11648/j.ejpm.20180605.12 T2 - European Journal of Preventive Medicine JF - European Journal of Preventive Medicine JO - European Journal of Preventive Medicine SP - 70 EP - 75 PB - Science Publishing Group SN - 2330-8230 UR - https://doi.org/10.11648/j.ejpm.20180605.12 AB - Both abdominal obesity and sarcopenia are associated with cardiometabolic disorders mainly in postmenopausal women. In addition, there appears to be a reverse association between abdominal obesity and sarcopenia. The objective of the study was to identify the association and the discriminatory power of abdominal obesity for the prevention of sarcopenia and vice versa in postmenopausal women. The sample includes 257 women with age 57,2 years, The abdominal obesity and the variables determinants of sarcopenia were assessed by bioelectrical impedance analysis. The association of variables was been tested using logistic regression and the discriminatory power through Receiver Operating Characteristic (ROC) considering a confidence interval of 95%. The presence of abdominal obesity with the cutoff point of 153 cm² of visceral fat was discriminatory power for sarcopenia, as well as the musculoskeletal mass index with the cuttof point of 35,2% discriminated the absence of abdominal obesity. After adjusting for confounders it was observed still association between abdominal obesity and sarcopenia and association between musculoskeletal mass index and absence of abdominal obesity. The results of the study suggest that abdominal obesity discriminates and is associated with sarcopenia, such as musculoskeletal mass index discriminates the absence and is inversely associated whit of abdominal obesity in postmenopausal women. VL - 6 IS - 5 ER -